Wegovy Cost Without Insurance in 2025
Modern Weight Science Editorial Team
Editorial Team
The list price for Wegovy runs over $1,300 per month — but almost nobody pays that. Here is what Wegovy actually costs in 2025 across every realistic payment path.
Wegovy's list price is approximately $1,349 per month in the United States as of 2025. That figure gets cited constantly and causes a lot of people to stop investigating further — which is a mistake, because very few people who access Wegovy actually pay anywhere near that amount.
Your real cost depends entirely on which payment path you take. Here is a clear breakdown of every realistic option.
Path 1: Novo Nordisk savings card (commercial insurance only)
If you have commercial insurance that covers Wegovy, Novo Nordisk's savings card can reduce your monthly out-of-pocket cost to as low as $0 for the first month and $25/month thereafter for eligible patients. Eligibility requirements:
- You must have commercial (employer or private marketplace) insurance
- Your plan must list Wegovy on its formulary
- You cannot be on Medicare, Medicaid, or other government payers
If your plan covers Wegovy and you qualify, this is by far the cheapest route. Check eligibility and enrol at the Wegovy official site — the card is linked directly to your prescription.
Path 2: Novo Nordisk patient assistance (uninsured, low income)
Novo Nordisk's Patient Assistance Program (NovaCare) provides free or heavily subsidised Wegovy for patients who are uninsured and meet income criteria. The application is through your prescriber's office and involves income documentation. If you qualify, you may receive the medication at no cost.
Path 3: Cash pay at full list price
Without insurance or a savings program, the out-of-pocket cost for brand-name Wegovy at a retail pharmacy is approximately $1,300–$1,400 per month depending on dose and location. Almost no one chooses this route for ongoing treatment — it exists primarily for people who need to bridge a gap in coverage.
Path 4: Compounded semaglutide through telehealth
This is the most common path for people paying out of pocket. Telehealth platforms offer compounded semaglutide — the same active ingredient as Wegovy, produced by licensed 503A/503B pharmacies — at dramatically lower prices:
- Typical range: $150–$500 per month all-in, including the prescription and medication
- No insurance required
- Available with a telehealth consultation rather than an in-person visit
The important caveat: compounded semaglutide is not FDA-approved as a finished product. The active ingredient is the same, but quality and sourcing vary by pharmacy. Choose a provider that is transparent about which 503A or 503B pharmacy fills their prescriptions.
Path 5: Wegovy via the Novo Nordisk direct programme
Novo Nordisk has introduced a direct-to-patient cash-pay option at $499/month for certain doses. Availability and eligibility have been limited and have changed over time — check the official Wegovy website for current terms, as this has not been universally accessible.
How the numbers compare at a glance
- Commercial insurance + savings card: $0–$25/month
- Patient assistance programme: $0 (income-qualified)
- Compounded semaglutide (telehealth): $150–$500/month
- Novo Nordisk direct cash programme: ~$499/month (where available)
- Full cash price at pharmacy: $1,300–$1,400/month
What actually determines your cost
The single most important variable is whether you have commercial insurance that lists Wegovy on formulary. If yes, the savings card makes it extremely affordable. If no, the compounded semaglutide market offers the most accessible cash-pay alternative. Prices and programmes change — always verify current terms directly with Novo Nordisk and the telehealth provider before committing.
Costs cited here reflect publicly available information as of May 2026. Drug prices, savings card terms, and programme availability change frequently. Confirm current pricing directly with your pharmacy, insurer, and any telehealth provider you are evaluating.
About the author
Modern Weight Science Editorial Team
Editorial Team
Evidence-based research and educational content focused on metabolism, appetite regulation, and sustainable weight management. Our team synthesizes peer-reviewed research into clear, accessible guidance for informed health decisions.
Content reviewed against peer-reviewed research. Read our editorial policy →
Last updated May 2026
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but they are FDA-approved for different indications. Ozempic (up to 2mg) is approved for type 2 diabetes management and cardiovascular risk reduction. Wegovy (up to 2.4mg) is approved for chronic weight management. The distinction directly affects insurance coverage, maximum dose, and prescribing eligibility — and the two are not interchangeable through most pharmacies.
Do I need a prescription for semaglutide or tirzepatide?
Yes. Semaglutide and tirzepatide are prescription-only medications in the United States and most countries. They require evaluation and a prescription from a licensed healthcare provider. Compounded versions have been available through telehealth platforms, but these are not FDA-approved and carry different regulatory and quality considerations.
How long does it take to see results on GLP-1 medications?
Appetite changes are typically noticed in weeks 1-2. Meaningful weight loss (5-10% of body weight) generally occurs by weeks 12-20. Clinical trial results are measured at 68-72 weeks. The dose escalation schedule means the first 16-20 weeks are primarily about building tolerance, not maximum efficacy. Individual response varies significantly.
What happens when you stop taking a GLP-1 medication?
Most people regain a significant portion of lost weight within 12 months of stopping. Discontinuation studies show that the compensatory hunger and metabolic changes that GLP-1 medications suppress tend to return when the medication is withdrawn. Many clinicians now frame these as long-term treatments — similar to antihypertensives — rather than short-term interventions.
Not medical advice. This guide is for general education only. GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.
Treatment Options
Clinically supervised approaches to metabolic health and weight management, evaluated by licensed physicians.
Ro Body
A physician-led telehealth program that evaluates your metabolic health and discusses FDA-cleared medication options where clinically appropriate.
Learn moreFound
Combines medical evaluation, pharmacotherapy when indicated, and behavioral coaching into a structured, ongoing metabolic health plan.
Learn moreCalibrate
A year-long metabolic reset built around GLP-1 medication, with physician oversight, registered dietitian support, and behavioral coaching.
Learn moreAffiliate disclosure: Modern Weight Science may earn a commission if you visit or purchase through these links, at no additional cost to you. Programs are listed for educational relevance. This is not a clinical recommendation — always consult a licensed healthcare professional before starting any treatment.
Weekly Digest
Get Evidence-Based Metabolic Health Insights Weekly
Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.
Continue reading
Related articles
Ozempic Price Without Insurance: What You'll Actually Pay
Ozempic's list price is around $935 per month, but that is rarely what people pay. Here is a straightforward breakdown of what Ozempic costs through every realistic route in 2025.
Ozempic vs. Wegovy: Same Drug, Different Purposes
Ozempic and Wegovy both contain semaglutide, yet they are not interchangeable. The distinction between the two shapes everything from your insurance coverage to the maximum dose your prescriber can offer.
Ozempic Savings Card: How to Pay $25/Month
Novo Nordisk's Ozempic savings card can reduce your monthly cost to $25 — but eligibility rules catch a lot of people off guard. Here is exactly how it works and who qualifies.
Best Telehealth for GLP-1 Prescriptions in 2025
The telehealth GLP-1 market is large, crowded, and uneven in quality. Here is a plain-language framework for evaluating providers — and the questions that actually separate good clinical care from a slick checkout page.